{"id":360991,"date":"2025-08-30T16:12:11","date_gmt":"2025-08-30T16:12:11","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-ucb\/"},"modified":"2025-08-30T16:12:11","modified_gmt":"2025-08-30T16:12:11","slug":"how-to-buy-ucb","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/","title":{"rendered":"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-360991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"UCB SA (UCB) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. Bu ila\u00e7 liderinin g\u00fcncel hisse performans\u0131n\u0131, b\u00fcy\u00fcme potansiyelini ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"UCB SA (UCB) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. Bu ila\u00e7 liderinin g\u00fcncel hisse performans\u0131n\u0131, b\u00fcy\u00fcme potansiyelini ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin."},"intro":"Patlay\u0131c\u0131 b\u00fcy\u00fcme g\u00f6steren bir ila\u00e7 devi yat\u0131r\u0131m\u0131n\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? UCB SA, yenilik\u00e7i n\u00f6roloji tedavilerini etkileyici finansal ivmeyle birle\u015ftiren Avrupa'n\u0131n en umut verici sa\u011fl\u0131k yat\u0131r\u0131mlar\u0131ndan biridir. %25 gelir art\u0131\u015f\u0131 ve stratejik ABD geni\u015fleme planlar\u0131yla, bu Bel\u00e7ika m\u00fccevheri, ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in hem istikrar hem de b\u00fcy\u00fcme potansiyeli sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Patlay\u0131c\u0131 b\u00fcy\u00fcme g\u00f6steren bir ila\u00e7 devi yat\u0131r\u0131m\u0131n\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? UCB SA, yenilik\u00e7i n\u00f6roloji tedavilerini etkileyici finansal ivmeyle birle\u015ftiren Avrupa'n\u0131n en umut verici sa\u011fl\u0131k yat\u0131r\u0131mlar\u0131ndan biridir. %25 gelir art\u0131\u015f\u0131 ve stratejik ABD geni\u015fleme planlar\u0131yla, bu Bel\u00e7ika m\u00fccevheri, ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in hem istikrar hem de b\u00fcy\u00fcme potansiyeli sunuyor."},"body_html":"<h2>\ud83d\udcc8 UCB Hisse Performans\u0131 ve Piyasa Konumu<\/h2> <p>30 A\u011fustos 2025 itibar\u0131yla, UCB SA (UCB) Euronext Br\u00fcksel'de <strong>\u20ac233,28<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. \u015eirket, 2025 y\u0131l\u0131n\u0131n ilk yar\u0131s\u0131ndaki ola\u011fan\u00fcst\u00fc sonu\u00e7lar\u0131n etkisiyle hisselerini \u20ac239,75'in \u00fczerindeki 52 haftal\u0131k yeni zirvelere ta\u015f\u0131yan pozitif bir ivme yakalad\u0131.<\/p> <p><strong>Takviminize not edin: \u015eubat 2026 kritik<\/strong> - UCB'nin bir sonraki b\u00fcy\u00fck kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketleri yarat\u0131r. 31 Temmuz 2025 kazan\u00e7lar\u0131na bak\u0131ld\u0131\u011f\u0131nda, hisse senedi a\u00e7\u0131klama \u00e7evresinde dikkat \u00e7ekici volatilite g\u00f6sterdi:<\/p> <ul> <li>9 Temmuz 2025: \u20ac203,26<\/li> <li>10 Temmuz 2025: \u20ac194,76 (%4,2 d\u00fc\u015f\u00fc\u015f)<\/li> <li>11 Temmuz 2025: \u20ac197,82 (toparlanma)<\/li> <li>14 Temmuz 2025: \u20ac203,85 (%3,1 art\u0131\u015f)<\/li> <\/ul> <p>Bu ilk belirsizlik ard\u0131ndan g\u00fc\u00e7l\u00fc toparlanma modeli, kazan\u00e7 raporlar\u0131n\u0131n UCB hisselerini tipik olarak nas\u0131l hareket ettirdi\u011fini g\u00f6steriyor. \u015eirketin beklentileri s\u00fcrekli a\u015fmas\u0131, yat\u0131r\u0131mc\u0131 g\u00fcvenini art\u0131rd\u0131.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalanmalardan Toparlanmaya<\/h3> <p>UCB hisseleri son alt\u0131 ayda \u00f6nemli volatilite ya\u015fad\u0131 ve bu d\u00f6nemde \u20ac155,90 ile \u20ac198,95 aras\u0131nda i\u015flem g\u00f6rd\u00fc<a href=\"https:\/\/www.klickanalytics.com\/symbol_hp?sid=251304\">(Klick Analytics)<\/a>. Dramatik dalgalanmalara ra\u011fmen, hisse dayan\u0131kl\u0131l\u0131k g\u00f6sterdi:<\/p> <p><strong>Ocak-Mart 2025<\/strong>: Hisseler Ocak ay\u0131 diplerinden \u20ac180 civar\u0131ndan \u20ac198 seviyelerine t\u0131rmand\u0131<br\/> <strong>Nisan-Haziran<\/strong>: Baz\u0131 kar realizasyonlar\u0131 fiyatlar\u0131 \u20ac190-195 seviyelerine geri getirdi<br\/> <strong>Temmuz-A\u011fustos<\/strong>: G\u00fc\u00e7l\u00fc 2. \u00e7eyrek kazan\u00e7lar\u0131 hisseyi \u20ac230 \u00fczerindeki yeni zirvelere ta\u015f\u0131d\u0131<\/p> <p>Genel alt\u0131 ayl\u0131k performans %1,36'l\u0131k hafif bir d\u00fc\u015f\u00fc\u015f g\u00f6sterse de<a href=\"https:\/\/www.klickanalytics.com\/symbol_performance?sid=251304\">(Klick Analytics Performans)<\/a>, bu son aylardaki %9,15'lik etkileyici ivmeyi gizliyor.<\/p> <h3>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h3> <p>Mevcut analist konsens\u00fcs\u00fc ve temel b\u00fcy\u00fcme projeksiyonlar\u0131na dayanarak, UCB uzun vadeli \u00e7ekici potansiyel sunuyor:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: \u20ac240-260 (g\u00fc\u00e7l\u00fc 2. yar\u0131 performans\u0131ndan devam eden ivme) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br\/> <strong>2026<\/strong>: \u20ac280-310 (ABD \u00fcretim geni\u015flemesinin tam faydas\u0131)<br\/> <strong>2028<\/strong>: \u20ac350-400 (pipeline \u00fcr\u00fcnlerinin olgunla\u015fmas\u0131)<br\/> <strong>2030<\/strong>: \u20ac450-500+ (n\u00f6roloji\/imm\u00fcnoloji alan\u0131nda k\u00fcresel pazar liderli\u011fi)<\/p> <p>Temel b\u00fcy\u00fcme hikayesi bu projeksiyonlar\u0131 destekliyor; kazan\u00e7lar\u0131n <strong>y\u0131ll\u0131k %17,4<\/strong> ve gelirlerin <strong>y\u0131ll\u0131k %10,2<\/strong> b\u00fcy\u00fcmesi bekleniyor<a href=\"https:\/\/simplywall.st\/stocks\/be\/pharmaceuticals-biotech\/ebr-ucb\/ucb-shares\/future\">(Simply Wall St)<\/a>.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi ve B\u00fcy\u00fcme Kataliz\u00f6rleri<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Potansiyel Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon zorluklar\u0131<\/strong>: \u0130la\u00e7 \u015firketleri FDA ve EMA gibi kurumlar\u0131n yo\u011fun denetimine tabidir<\/li> <li><strong>Patent s\u00fcresi dolmalar\u0131<\/strong>: \u00d6nemli \u00fcr\u00fcnler \u00f6n\u00fcm\u00fczdeki y\u0131llarda jenerik rekabetle kar\u015f\u0131la\u015fabilir<\/li> <li><strong>D\u00f6viz riski<\/strong>: Gelirin %68'i yurtd\u0131\u015f\u0131 piyasalardan geliyor<\/li> <li><strong>Ar-Ge ba\u015far\u0131s\u0131zl\u0131k riski<\/strong>: Y\u00fcksek maliyetli ila\u00e7 geli\u015ftirme do\u011fal olarak ba\u015far\u0131s\u0131zl\u0131k ihtimali ta\u015f\u0131r<\/li> <\/ul> <h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Patlay\u0131c\u0131 b\u00fcy\u00fcme<\/strong>: 2025 ilk yar\u0131s\u0131nda %25 gelir art\u0131\u015f\u0131 ile \u20ac3,49 milyar<a href=\"https:\/\/www.ucb.com\/sites\/default\/files\/2025-07\/ucb_half-year_2025_report-en-final.pdf\">(UCB H1 2025 Raporu)<\/a><\/li> <li><strong>\u00dcretim geni\u015flemesi<\/strong>: 5 milyar $ de\u011ferinde ABD tesisi, 800'den fazla i\u015f yaratacak<a href=\"https:\/\/www.ucb.com\/newsroom\/press-releases\/article\/from-differentiated-innovation-to-outstanding-delivery-a-strong-first-half-performance\">(UCB Bas\u0131n B\u00fclteni)<\/a><\/li> <li><strong>Analist y\u00fckseltmeleri<\/strong>: Morgan Stanley 'overweight' (a\u011f\u0131rl\u0131kl\u0131 al\u0131m) notu verdi<\/li> <li><strong>Pipeline g\u00fcc\u00fc<\/strong>: 14 ileri a\u015fama \u00fcr\u00fcn aday\u0131 geli\u015ftirme a\u015famas\u0131nda<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/strong>: Sekt\u00f6r volatilitesi nedeniyle portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10'undan fazlas\u0131n\u0131 UCB'ye ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong>: Piyasay\u0131 zamanlamaya \u00e7al\u0131\u015fmak yerine sabit miktarlarda ayl\u0131k yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in \u015eubat 2026 kazan\u00e7lar\u0131n\u0131 takip edin<\/li> <li><strong>Sekt\u00f6rler aras\u0131nda \u00e7e\u015fitlendirin<\/strong>: \u0130la\u00e7 sekt\u00f6r\u00fcndeki pozisyonunuzu di\u011fer sekt\u00f6rlerle dengeleyin<\/li> <\/ol> <p>Esprili t\u00fcccar bilgeli\u011fi: \"UCB ticareti, n\u00f6roloji ara\u015ft\u0131rmalar\u0131 gibidir - bazen klinik deneme a\u015famalar\u0131nda g\u00fc\u00e7l\u00fc sinirlere ihtiyac\u0131n\u0131z olur, ancak \u00e7\u0131\u011f\u0131r a\u00e7an sonu\u00e7lar volatiliteye de\u011fer!\"<\/p> <h2>\u2705 UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>Euronext Br\u00fcksel borsas\u0131na eri\u015fim sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Uyumluluk i\u00e7in gerekli belgeleri sa\u011flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"UCB\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>Bel\u00e7ika listesi i\u00e7in do\u011fru sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td><td>\u00dccretleri ve d\u00f6viz kurlar\u0131n\u0131 kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin<\/td><td>\u0130\u015flem detaylar\u0131n\u0131 onaylay\u0131n<\/td><\/tr> <tr><td>8<\/td><td>Pozisyonu izleyin<\/td><td>Fiyat hareketleri i\u00e7in uyar\u0131lar kurun<\/td><\/tr> <tr><td>9<\/td><td>Temett\u00fc yeniden yat\u0131r\u0131m\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td><td>UCB, hissedarlara getiri sunar<\/td><\/tr> <tr><td>10<\/td><td>Portf\u00f6y da\u011f\u0131l\u0131m\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td><td>Uygun \u00e7e\u015fitlendirmeyi sa\u011flay\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option'un \u00d6ne \u00c7\u0131kma Nedenleri<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, <strong>sadece 5 $ minimum depozito<\/strong> ile ola\u011fan\u00fcst\u00fc eri\u015filebilirlik sunar - stratejileri d\u00fc\u015f\u00fck riskle test etmenize olanak tan\u0131r. Platform, <strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> sa\u011flar ve tek bir belge ile i\u015flem yap\u0131labilir. Ayr\u0131ca, kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k y\u00f6ntemleri dahil olmak \u00fczere <strong>100'den fazla para \u00e7ekme se\u00e7ene\u011fi<\/strong> sunar.<\/p> <p>D\u00fc\u015f\u00fck giri\u015f engelleri ve esnek ticaret se\u00e7enekleri kombinasyonu, UCB gibi Avrupa hisselerinde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option'u \u00f6zellikle cazip k\u0131lar.<\/p> <h2>\ud83c\udf0d 2025'te UCB: \u0130la\u00e7ta Yenilik Lideri<\/h2> <p>UCB SA, n\u00f6roloji ve imm\u00fcnoloji tedavi alan\u0131nda <strong>37 milyar \u20ac<\/strong> piyasa de\u011feri ile lider konumdad\u0131r<a href=\"https:\/\/stockanalysis.com\/quote\/otc\/UCBJF\/history\/\">(Stock Analysis)<\/a>. \u015eirket, \u00f6zellikle epilepsi, Parkinson ve otoimm\u00fcn hastal\u0131klar gibi ciddi hastal\u0131klar\u0131n tedavisine odaklanmaktad\u0131r.<\/p> <p><strong>2025 ilgin\u00e7 ger\u00e7ek<\/strong>: UCB'nin yeni ABD biyolojik \u00fcretim tesisi, son y\u0131llar\u0131n en b\u00fcy\u00fck ila\u00e7 yat\u0131r\u0131mlar\u0131ndan biridir ve <strong>300 kal\u0131c\u0131 uzman i\u015f ve 500 in\u015faat pozisyonu<\/strong> yaratmas\u0131 beklenirken, <strong>5 milyar $ ekonomik etki<\/strong> yaratacakt\u0131r<a href=\"https:\/\/www.ucb.com\/newsroom\/press-releases\/article\/from-differentiated-innovation-to-outstanding-delivery-a-strong-first-half-performance\">(UCB Stratejik Yat\u0131r\u0131m)<\/a>. Bu geni\u015fleme, artan hasta talebini kar\u015f\u0131lamaya ve k\u00fcresel tedarik zincirlerini g\u00fc\u00e7lendirmeye olan ba\u011fl\u0131l\u0131klar\u0131n\u0131 vurgulamaktad\u0131r.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 UCB Hisse Performans\u0131 ve Piyasa Konumu<\/h2>\n<p>30 A\u011fustos 2025 itibar\u0131yla, UCB SA (UCB) Euronext Br\u00fcksel&#8217;de <strong>\u20ac233,28<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. \u015eirket, 2025 y\u0131l\u0131n\u0131n ilk yar\u0131s\u0131ndaki ola\u011fan\u00fcst\u00fc sonu\u00e7lar\u0131n etkisiyle hisselerini \u20ac239,75&#8217;in \u00fczerindeki 52 haftal\u0131k yeni zirvelere ta\u015f\u0131yan pozitif bir ivme yakalad\u0131.<\/p>\n<p><strong>Takviminize not edin: \u015eubat 2026 kritik<\/strong> &#8211; UCB&#8217;nin bir sonraki b\u00fcy\u00fck kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketleri yarat\u0131r. 31 Temmuz 2025 kazan\u00e7lar\u0131na bak\u0131ld\u0131\u011f\u0131nda, hisse senedi a\u00e7\u0131klama \u00e7evresinde dikkat \u00e7ekici volatilite g\u00f6sterdi:<\/p>\n<ul>\n<li>9 Temmuz 2025: \u20ac203,26<\/li>\n<li>10 Temmuz 2025: \u20ac194,76 (%4,2 d\u00fc\u015f\u00fc\u015f)<\/li>\n<li>11 Temmuz 2025: \u20ac197,82 (toparlanma)<\/li>\n<li>14 Temmuz 2025: \u20ac203,85 (%3,1 art\u0131\u015f)<\/li>\n<\/ul>\n<p>Bu ilk belirsizlik ard\u0131ndan g\u00fc\u00e7l\u00fc toparlanma modeli, kazan\u00e7 raporlar\u0131n\u0131n UCB hisselerini tipik olarak nas\u0131l hareket ettirdi\u011fini g\u00f6steriyor. \u015eirketin beklentileri s\u00fcrekli a\u015fmas\u0131, yat\u0131r\u0131mc\u0131 g\u00fcvenini art\u0131rd\u0131.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalanmalardan Toparlanmaya<\/h3>\n<p>UCB hisseleri son alt\u0131 ayda \u00f6nemli volatilite ya\u015fad\u0131 ve bu d\u00f6nemde \u20ac155,90 ile \u20ac198,95 aras\u0131nda i\u015flem g\u00f6rd\u00fc<a href=\"https:\/\/www.klickanalytics.com\/symbol_hp?sid=251304\">(Klick Analytics)<\/a>. Dramatik dalgalanmalara ra\u011fmen, hisse dayan\u0131kl\u0131l\u0131k g\u00f6sterdi:<\/p>\n<p><strong>Ocak-Mart 2025<\/strong>: Hisseler Ocak ay\u0131 diplerinden \u20ac180 civar\u0131ndan \u20ac198 seviyelerine t\u0131rmand\u0131<br \/> <strong>Nisan-Haziran<\/strong>: Baz\u0131 kar realizasyonlar\u0131 fiyatlar\u0131 \u20ac190-195 seviyelerine geri getirdi<br \/> <strong>Temmuz-A\u011fustos<\/strong>: G\u00fc\u00e7l\u00fc 2. \u00e7eyrek kazan\u00e7lar\u0131 hisseyi \u20ac230 \u00fczerindeki yeni zirvelere ta\u015f\u0131d\u0131<\/p>\n<p>Genel alt\u0131 ayl\u0131k performans %1,36&#8217;l\u0131k hafif bir d\u00fc\u015f\u00fc\u015f g\u00f6sterse de<a href=\"https:\/\/www.klickanalytics.com\/symbol_performance?sid=251304\">(Klick Analytics Performans)<\/a>, bu son aylardaki %9,15&#8217;lik etkileyici ivmeyi gizliyor.<\/p>\n<h3>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h3>\n<p>Mevcut analist konsens\u00fcs\u00fc ve temel b\u00fcy\u00fcme projeksiyonlar\u0131na dayanarak, UCB uzun vadeli \u00e7ekici potansiyel sunuyor:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: \u20ac240-260 (g\u00fc\u00e7l\u00fc 2. yar\u0131 performans\u0131ndan devam eden ivme) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> <strong>2026<\/strong>: \u20ac280-310 (ABD \u00fcretim geni\u015flemesinin tam faydas\u0131)<br \/> <strong>2028<\/strong>: \u20ac350-400 (pipeline \u00fcr\u00fcnlerinin olgunla\u015fmas\u0131)<br \/> <strong>2030<\/strong>: \u20ac450-500+ (n\u00f6roloji\/imm\u00fcnoloji alan\u0131nda k\u00fcresel pazar liderli\u011fi)<\/p>\n<p>Temel b\u00fcy\u00fcme hikayesi bu projeksiyonlar\u0131 destekliyor; kazan\u00e7lar\u0131n <strong>y\u0131ll\u0131k %17,4<\/strong> ve gelirlerin <strong>y\u0131ll\u0131k %10,2<\/strong> b\u00fcy\u00fcmesi bekleniyor<a href=\"https:\/\/simplywall.st\/stocks\/be\/pharmaceuticals-biotech\/ebr-ucb\/ucb-shares\/future\">(Simply Wall St)<\/a>.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi ve B\u00fcy\u00fcme Kataliz\u00f6rleri<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Potansiyel Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon zorluklar\u0131<\/strong>: \u0130la\u00e7 \u015firketleri FDA ve EMA gibi kurumlar\u0131n yo\u011fun denetimine tabidir<\/li>\n<li><strong>Patent s\u00fcresi dolmalar\u0131<\/strong>: \u00d6nemli \u00fcr\u00fcnler \u00f6n\u00fcm\u00fczdeki y\u0131llarda jenerik rekabetle kar\u015f\u0131la\u015fabilir<\/li>\n<li><strong>D\u00f6viz riski<\/strong>: Gelirin %68&#8217;i yurtd\u0131\u015f\u0131 piyasalardan geliyor<\/li>\n<li><strong>Ar-Ge ba\u015far\u0131s\u0131zl\u0131k riski<\/strong>: Y\u00fcksek maliyetli ila\u00e7 geli\u015ftirme do\u011fal olarak ba\u015far\u0131s\u0131zl\u0131k ihtimali ta\u015f\u0131r<\/li>\n<\/ul>\n<h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Patlay\u0131c\u0131 b\u00fcy\u00fcme<\/strong>: 2025 ilk yar\u0131s\u0131nda %25 gelir art\u0131\u015f\u0131 ile \u20ac3,49 milyar<a href=\"https:\/\/www.ucb.com\/sites\/default\/files\/2025-07\/ucb_half-year_2025_report-en-final.pdf\">(UCB H1 2025 Raporu)<\/a><\/li>\n<li><strong>\u00dcretim geni\u015flemesi<\/strong>: 5 milyar $ de\u011ferinde ABD tesisi, 800&#8217;den fazla i\u015f yaratacak<a href=\"https:\/\/www.ucb.com\/newsroom\/press-releases\/article\/from-differentiated-innovation-to-outstanding-delivery-a-strong-first-half-performance\">(UCB Bas\u0131n B\u00fclteni)<\/a><\/li>\n<li><strong>Analist y\u00fckseltmeleri<\/strong>: Morgan Stanley &#8216;overweight&#8217; (a\u011f\u0131rl\u0131kl\u0131 al\u0131m) notu verdi<\/li>\n<li><strong>Pipeline g\u00fcc\u00fc<\/strong>: 14 ileri a\u015fama \u00fcr\u00fcn aday\u0131 geli\u015ftirme a\u015famas\u0131nda<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/strong>: Sekt\u00f6r volatilitesi nedeniyle portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10&#8217;undan fazlas\u0131n\u0131 UCB&#8217;ye ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong>: Piyasay\u0131 zamanlamaya \u00e7al\u0131\u015fmak yerine sabit miktarlarda ayl\u0131k yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Potansiyel giri\u015f noktalar\u0131 i\u00e7in \u015eubat 2026 kazan\u00e7lar\u0131n\u0131 takip edin<\/li>\n<li><strong>Sekt\u00f6rler aras\u0131nda \u00e7e\u015fitlendirin<\/strong>: \u0130la\u00e7 sekt\u00f6r\u00fcndeki pozisyonunuzu di\u011fer sekt\u00f6rlerle dengeleyin<\/li>\n<\/ol>\n<p>Esprili t\u00fcccar bilgeli\u011fi: &#8220;UCB ticareti, n\u00f6roloji ara\u015ft\u0131rmalar\u0131 gibidir &#8211; bazen klinik deneme a\u015famalar\u0131nda g\u00fc\u00e7l\u00fc sinirlere ihtiyac\u0131n\u0131z olur, ancak \u00e7\u0131\u011f\u0131r a\u00e7an sonu\u00e7lar volatiliteye de\u011fer!&#8221;<\/p>\n<h2>\u2705 UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>Euronext Br\u00fcksel borsas\u0131na eri\u015fim sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Uyumluluk i\u00e7in gerekli belgeleri sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;UCB&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>Bel\u00e7ika listesi i\u00e7in do\u011fru sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>\u00dccretleri ve d\u00f6viz kurlar\u0131n\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin<\/td>\n<td>\u0130\u015flem detaylar\u0131n\u0131 onaylay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Fiyat hareketleri i\u00e7in uyar\u0131lar kurun<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Temett\u00fc yeniden yat\u0131r\u0131m\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>UCB, hissedarlara getiri sunar<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Portf\u00f6y da\u011f\u0131l\u0131m\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>Uygun \u00e7e\u015fitlendirmeyi sa\u011flay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option&#8217;un \u00d6ne \u00c7\u0131kma Nedenleri<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, <strong>sadece 5 $ minimum depozito<\/strong> ile ola\u011fan\u00fcst\u00fc eri\u015filebilirlik sunar &#8211; stratejileri d\u00fc\u015f\u00fck riskle test etmenize olanak tan\u0131r. Platform, <strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> sa\u011flar ve tek bir belge ile i\u015flem yap\u0131labilir. Ayr\u0131ca, kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k y\u00f6ntemleri dahil olmak \u00fczere <strong>100&#8217;den fazla para \u00e7ekme se\u00e7ene\u011fi<\/strong> sunar.<\/p>\n<p>D\u00fc\u015f\u00fck giri\u015f engelleri ve esnek ticaret se\u00e7enekleri kombinasyonu, UCB gibi Avrupa hisselerinde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option&#8217;u \u00f6zellikle cazip k\u0131lar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te UCB: \u0130la\u00e7ta Yenilik Lideri<\/h2>\n<p>UCB SA, n\u00f6roloji ve imm\u00fcnoloji tedavi alan\u0131nda <strong>37 milyar \u20ac<\/strong> piyasa de\u011feri ile lider konumdad\u0131r<a href=\"https:\/\/stockanalysis.com\/quote\/otc\/UCBJF\/history\/\">(Stock Analysis)<\/a>. \u015eirket, \u00f6zellikle epilepsi, Parkinson ve otoimm\u00fcn hastal\u0131klar gibi ciddi hastal\u0131klar\u0131n tedavisine odaklanmaktad\u0131r.<\/p>\n<p><strong>2025 ilgin\u00e7 ger\u00e7ek<\/strong>: UCB&#8217;nin yeni ABD biyolojik \u00fcretim tesisi, son y\u0131llar\u0131n en b\u00fcy\u00fck ila\u00e7 yat\u0131r\u0131mlar\u0131ndan biridir ve <strong>300 kal\u0131c\u0131 uzman i\u015f ve 500 in\u015faat pozisyonu<\/strong> yaratmas\u0131 beklenirken, <strong>5 milyar $ ekonomik etki<\/strong> yaratacakt\u0131r<a href=\"https:\/\/www.ucb.com\/newsroom\/press-releases\/article\/from-differentiated-innovation-to-outstanding-delivery-a-strong-first-half-performance\">(UCB Stratejik Yat\u0131r\u0131m)<\/a>. Bu geni\u015fleme, artan hasta talebini kar\u015f\u0131lamaya ve k\u00fcresel tedarik zincirlerini g\u00fc\u00e7lendirmeye olan ba\u011fl\u0131l\u0131klar\u0131n\u0131 vurgulamaktad\u0131r.<\/p>\n"},"faq":[{"question":"UCB SA hisseleri nereden al\u0131nabilir?","answer":"UCB SA hisseleri, Euronext Br\u00fcksel borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"UCB hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 platforma g\u00f6re de\u011fi\u015fir. \u00d6rne\u011fin, Pocket Option platformunda sadece 5 $ minimum depozito ile yat\u0131r\u0131m yapabilirsiniz."},{"question":"UCB hisselerinin gelecekteki fiyat tahmini nedir?","answer":"Analistlerin tahminlerine g\u00f6re, UCB hisseleri 2025 sonunda \u20ac240-260, 2030 y\u0131l\u0131nda ise \u20ac450-500+ seviyelerine ula\u015fabilir."},{"question":"UCB hisseleri yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon zorluklar\u0131, patent s\u00fcresi dolmalar\u0131, d\u00f6viz riski ve Ar-Ge ba\u015far\u0131s\u0131zl\u0131klar\u0131 gibi riskler bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar UCB hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc s\u0131n\u0131rlamak, dolar maliyeti ortalamas\u0131 kullanmak, fiyat uyar\u0131lar\u0131 kurmak ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek yeni ba\u015flayanlar i\u00e7in \u00f6nerilen stratejilerdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"UCB SA hisseleri nereden al\u0131nabilir?","answer":"UCB SA hisseleri, Euronext Br\u00fcksel borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"UCB hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 platforma g\u00f6re de\u011fi\u015fir. \u00d6rne\u011fin, Pocket Option platformunda sadece 5 $ minimum depozito ile yat\u0131r\u0131m yapabilirsiniz."},{"question":"UCB hisselerinin gelecekteki fiyat tahmini nedir?","answer":"Analistlerin tahminlerine g\u00f6re, UCB hisseleri 2025 sonunda \u20ac240-260, 2030 y\u0131l\u0131nda ise \u20ac450-500+ seviyelerine ula\u015fabilir."},{"question":"UCB hisseleri yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon zorluklar\u0131, patent s\u00fcresi dolmalar\u0131, d\u00f6viz riski ve Ar-Ge ba\u015far\u0131s\u0131zl\u0131klar\u0131 gibi riskler bulunmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar UCB hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc s\u0131n\u0131rlamak, dolar maliyeti ortalamas\u0131 kullanmak, fiyat uyar\u0131lar\u0131 kurmak ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmek yeni ba\u015flayanlar i\u00e7in \u00f6nerilen stratejilerdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T16:12:11+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-30T16:12:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/\",\"name\":\"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-30T16:12:11+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/","og_locale":"tr_TR","og_type":"article","og_title":"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T16:12:11+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-30T16:12:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/","name":"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r - UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-30T16:12:11+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ucb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"UCB SA (UCB) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; UCB SA (UCB) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":360992,"slug":"how-to-buy-ucb","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu UCB SA (UCB) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu UCB SA (UCB)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ucb\/"},"pt_AA":{"locale":"pt_AA","id":360989,"slug":"how-to-buy-ucb","post_title":"Como comprar a\u00e7\u00f5es da UCB SA (UCB) - Investimento em a\u00e7\u00f5es da UCB SA (UCB)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ucb\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/360991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=360991"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/360991\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=360991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=360991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=360991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}